Abstract
Background: Silver nanofabricated products are well known elements from ages, and have great demand at present due to their massive significance in therapeutics, diagnostics, theranostics and targeted drug delivery systems. Silver nanoparticles (AgNPs) came into limelight, owing to their diverse pharmacotherapeutic potentials such as antiproliferative, anti-infective, anti-inflammatory, anti-coagulant etc. This resulted in increased commercial production of AgNPs and Ag-related products at highest pace. In majority of commercial AgNP production, traditionally wet chemical reduction techniques are employed that utilize chemicals that are non-ecofriendly, produce by-products, emit harmful substances and are expensive. Plant extracts are most environment friendly, easily available and are economically viable. The biological mediated approach serves as the most promising alternative to synthesize size-controlled AgNPs commercially.
Method: We undertook a search of bibliographic and patent databases for peer-reviewed research literature using a conceptual framework. The quality screened papers and patents were classified, judged and included for the study. Result: The study revealed that AgNPs have potential as nanomedicine owing to their diverse activity. About 91 different plants and 16 patented methods were highlighted along with mechanism of actions for the fabrication of nanoparticles. Conclusion: This article exclusively focuses on simple, environment friendly, size/shapecontrolled synthesis of AgNPs using plant extracts and highlights the knowledge of existing plant resources for producing nanomaterials.Keywords: Extract, green synthesis, nanomedicine, nanoparticles, patents, silver.
Graphical Abstract
Current Nanomedicine
Title:Nature Inspired Green Fabrication Technology for Silver Nanoparticles
Volume: 7 Issue: 1
Author(s): Debarshi Kar Mahapatra, Sanjay Kumar Bharti and Vivek Asati
Affiliation:
Keywords: Extract, green synthesis, nanomedicine, nanoparticles, patents, silver.
Abstract: Background: Silver nanofabricated products are well known elements from ages, and have great demand at present due to their massive significance in therapeutics, diagnostics, theranostics and targeted drug delivery systems. Silver nanoparticles (AgNPs) came into limelight, owing to their diverse pharmacotherapeutic potentials such as antiproliferative, anti-infective, anti-inflammatory, anti-coagulant etc. This resulted in increased commercial production of AgNPs and Ag-related products at highest pace. In majority of commercial AgNP production, traditionally wet chemical reduction techniques are employed that utilize chemicals that are non-ecofriendly, produce by-products, emit harmful substances and are expensive. Plant extracts are most environment friendly, easily available and are economically viable. The biological mediated approach serves as the most promising alternative to synthesize size-controlled AgNPs commercially.
Method: We undertook a search of bibliographic and patent databases for peer-reviewed research literature using a conceptual framework. The quality screened papers and patents were classified, judged and included for the study. Result: The study revealed that AgNPs have potential as nanomedicine owing to their diverse activity. About 91 different plants and 16 patented methods were highlighted along with mechanism of actions for the fabrication of nanoparticles. Conclusion: This article exclusively focuses on simple, environment friendly, size/shapecontrolled synthesis of AgNPs using plant extracts and highlights the knowledge of existing plant resources for producing nanomaterials.Export Options
About this article
Cite this article as:
Mahapatra Kar Debarshi, Bharti Kumar Sanjay and Asati Vivek, Nature Inspired Green Fabrication Technology for Silver Nanoparticles, Current Nanomedicine 2017; 7 (1) . https://dx.doi.org/10.2174/2468187306666160927122028
DOI https://dx.doi.org/10.2174/2468187306666160927122028 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Molecular Targeted Approaches for Treatment of Pancreatic Cancer
Current Pharmaceutical Design Malignant Phyllodes Tumors with Heterologous Sarcomatous Elements Presenting as Hyperechoic Masses on Ultrasonography: A Case Report
Current Medical Imaging Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy
Current Drug Targets Recent Patents in the Field of Radioprotector Development: Opportunities and Challenges
Recent Patents on Biotechnology Anti-Tumor Necrosis Factor Blocking Agents in the Treatment of Systemic Vasculitis
Current Immunology Reviews (Discontinued) Ischemic Post-Conditioning Partially Reverses Cell Cycle Reactivity Following Ischemia/Reperfusion Injury: A Genome-Wide Survey
CNS & Neurological Disorders - Drug Targets A Five-gene Signature for Predicting the Prognosis of Colorectal Cancer
Current Gene Therapy Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry Developmental Regulated Expression of Anti- and Pro-Apoptotic BCL-2 Family Genes During Human Early Embryonic Development
Current Medicinal Chemistry Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Antitumor Potential and Possible Targets of Phenothiazine-Related Compounds
Current Drug Targets Preface [Hot topic: Histone Deacetylase Inhibitors (Guest Editor: Kristof Van Emelen)]
Current Medicinal Chemistry MicroRNA and Cancer: Tiny Molecules with Major Implications
Current Genomics Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Innate and Adaptive Immune Responses in Chronic HCV Infection
Current Drug Targets Oxidative Stress in Atherosclerosis Development: The Central Role of LDL and Oxidative Burst
Endocrine, Metabolic & Immune Disorders - Drug Targets Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets HOX Genes as Potential Markers of Circulating Tumour Cells
Current Molecular Medicine